196 related articles for article (PubMed ID: 33680937)
1. Downregulation of the lncRNA ASB16-AS1 Decreases LARP1 Expression and Promotes Clear Cell Renal Cell Carcinoma Progression
Li M; Yin B; Chen M; Peng J; Mu X; Deng Z; Xiao J; Li W; Fan J
Front Oncol; 2020; 10():617105. PubMed ID: 33680937
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ASB16-AS1 Promotes Growth And Invasion Of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis And Activating Wnt/β-Catenin Pathway.
Yao X; You G; Zhou C; Zhang D
Cancer Manag Res; 2019; 11():9371-9378. PubMed ID: 31807066
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1.
Yang X; Zhang Y; Fan H
Cancer Gene Ther; 2021 Aug; 28(7-8):813-827. PubMed ID: 32719443
[TBL] [Abstract][Full Text] [Related]
5. [LncRNA ASB16-AS1 regulates the proliferation, migration and invasion of esophageal cancer cells by targeting miR-1258].
Jia Z; Wang PS; Yang Y; Zhu DY; Wang ZH; Wang W
Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):762-768. PubMed ID: 34289570
[No Abstract] [Full Text] [Related]
6. OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21.
Wang Z; Xia F; Feng T; Jiang B; Wang W; Li X
Front Endocrinol (Lausanne); 2020; 11():136. PubMed ID: 32256450
[No Abstract] [Full Text] [Related]
7. Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression.
Yin R; Liu J; Zhao D; Wang F
Onco Targets Ther; 2020; 13():2261-2274. PubMed ID: 32214826
[TBL] [Abstract][Full Text] [Related]
8. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ASB16-AS1 accelerates cellular process and chemoresistance of ovarian cancer cells by regulating GOLM1 expression via targeting miR-3918.
Fan Y; Wang L; Han X; Ma H; Zhang N; She L
Biochem Biophys Res Commun; 2023 Oct; 675():1-9. PubMed ID: 37429067
[TBL] [Abstract][Full Text] [Related]
10. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
11. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
Front Genet; 2020; 11():1030. PubMed ID: 33101368
[TBL] [Abstract][Full Text] [Related]
12. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
Tao M; Zhou Y; Jin Y; Pu J
Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
He H; Wang N; Yi X; Tang C; Wang D
Cell Biosci; 2017; 7():65. PubMed ID: 29214011
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG5 affects the invasion and apoptosis of renal cell carcinoma by regulating the miR-363-3p-Twist1 interaction.
Li WZ; Zou Y; Song ZY; Wei ZW; Chen G; Cai QL; Wang Z
Am J Transl Res; 2020; 12(2):697-707. PubMed ID: 32194916
[TBL] [Abstract][Full Text] [Related]
18. The downregulated long noncoding RNA
Wang C; Wang G; Zhang Z; Wang Z; Ren M; Wang X; Li H; Yu Y; Liu J; Cai L; Li Y; Zhang D; Zhang C
Onco Targets Ther; 2018; 11():5631-5646. PubMed ID: 30254456
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
Meng X; Ma J; Wang B; Wu X; Liu Z
J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
[TBL] [Abstract][Full Text] [Related]
20. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
